Navigation Links
AlloCure Inc. Closes $14.5MM Series A Round to Develop a Stem Cell Therapy for Acute Kidney Injury
Date:7/2/2008

r the next few years."

The company will use the investment to fund the progression of its acute kidney disease therapy through Phase II Clinical Trials over the next three years. Funds will also be used to develop a robust pipeline targeting other large medical markets where its cell therapy technology can address chronic unmet needs.

About AlloCure

AlloCure is poised to become the first company to commercialize effective cell therapies to treat various kidney diseases, organ transplants, multi-organ injury and a number of other difficult to treat diseases. AlloCure has developed a proprietary process to manufacture cells derived from bone marrow which can be used in an allogeneic (does not require tissue matching of donor and recipient) or off-the-shelf setting. AlloCure's technology has multiple therapeutic applications which have the potential to effectively address many large medical markets. http://www.allocure.com

About SV Life Sciences

SV Life Sciences is a venture capital fund providing financing to businesses at all stages of development across the human life sciences sector, including biotechnology, pharmaceuticals, medical devices and instruments, and healthcare information technology and services. SV Life Sciences currently manages or advises five funds with capital commitments of approximately $1.6 billion. http://www.svlifesciences.com

About Novo A/B

Novo A/S is the holding company of the Novo Group, and is wholly owned by the Novo Nordisk Foundation. Novo A/S was established in 1999 to manage the assets of the Foundation and actively make investments on behalf of the Foundation. The Novo Ventures team consists of six Partners in Copenhagen, one in London and two in San Francisco. With an evergreen structure, Novo A/S annually invests approximately $100 million in venture capital into private lif
'/>"/>

SOURCE AlloCure Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. OncoVista, Inc. Closes on $6.8 Million Financing and Acquires Control of a Public Shell Company
2. Genmab Discloses Target and Development Plans for HuMax-Inflam
3. Oxford Finance Corporation Closes $7 Million Debt Facility with Othera Pharmaceuticals
4. RoundTable Healthcare Partners Closes Sale of MedAssist Holding, Inc. to Firstsource Solutions Limited
5. Gilde Healthcare Partners Closes EUR 150 Million European Healthcare Venture Fund
6. Symmetry Medical Discloses Accounting Issues at Sheffield, UK Operating Unit and Possible Restatement
7. BioVex Closes Second Round of Series E Financing
8. Pharmaxis Closes Share Purchase Plan
9. The closest look ever at native human tissue
10. Helix BioPharma closes $16.9 million private placement of common shares
11. Senesco Technologies Closes on Additional $4.0 Million of Previously Announced Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... at Indiana University Bloomington have described the self-assembly ... development with potential value for the field of ... photovoltaic cells. , Their paper, "Anion-Induced Dimerization of ... 2D Self-Assembled Crystals," has been published online by ... Royal Society of Chemistry. It is the first ...
(Date:7/31/2014)... Graphite Metallizing Corporation announces GRAPHALLOY® ... bearings are uniquely suited to prevent loss of lubrication ... the high temperatures . , Recently, a manufacturer ... engineers at Graphite Metallizing to overcome problems with movement ... operation, pans containing blocks of powder mixture are loaded ...
(Date:7/31/2014)... Francisco, California (PRWEB) July 31, 2014 ... systems that inform therapeutic decision-making in oncology, today announced ... August 14, 2014 to discuss the Company's financial results ... provide an update about the business in the current ... audio call beginning on Thursday, August 14, 2014, at ...
(Date:7/31/2014)... Held at the Stanford Cancer Center, ... of the disease and its treatment. Survivors will find ... well as updates on the state-of-the-art with respect to ... for organizing this educational opportunity,” says KCA CEO Bill ... her colleagues have put together a program that balances ...
Breaking Biology Technology:Chemists demonstrate 'bricks-and-mortar' assembly of new molecular structures 2Chemists demonstrate 'bricks-and-mortar' assembly of new molecular structures 3Graphite Metallizing Announces Bearings for High Temperature Oven Applications 2Graphite Metallizing Announces Bearings for High Temperature Oven Applications 3CollabRx, Inc. Schedules First Quarter Fiscal Year 2015 Financial Conference Call and Business Update 2
... Dialysis Corporation,of America (Nasdaq: DCAI ) announced today ... on May 7, 2008, after the close of the,market. ... conjunction with,its first quarter 2008 earnings release the following ... interested in participating in the May 8, 2008 conference ...
... 25 Processes and products based on,biomass and ... industry in a wide range of applications such ... of industrial,biotechnology in Germany will be held at ... 27-30, 2008) in Chicago, Illinois.,The panel runs from ...
... Leader Discusses Pioneer Hi-Bred Biotechnology Leadership ... at Beijing ... ),partnerships with China,s public and private sectors will help increase,farm productivity ... William S. Niebur, vice president -- DuPont Crop,Genetics Research and Development, ...
Cached Biology Technology:Dialysis Corporation of America Announces First Quarter 2008 Earnings Release Date 2World Congress on Industrial Biotechnology: Germany Home to Top Biotech Research and Investment 2DuPont Partnering with China to Increase Farm Productivity 2DuPont Partnering with China to Increase Farm Productivity 3
(Date:7/31/2014)... flowers- they are an iconic symbol of tropical ... the landscape. Some, like Hawaii,s State Flower- ... a relatively few botanists and Hawaiian conservation workers, ... intriguing related group of plants known as ... of Hibiscus species are in fact highly endangered. ...
(Date:7/31/2014)... Conn. , July 31, 2014 ... the growing m-commerce market, reminds investors and consumers ... smart wallet, Wocket™, that it will be on-air today, ... secure Wocket smart wallet will be featured in ... oriented television show that airs on the History ...
(Date:7/30/2014)... truffle uses reversible epigenetic processes to regulate its genes, ... - a picture of the genome regulation taking place ... journal Genome Biology and illustrates how the ... ,jumping genes,. The authors say this may shed light ... , Black truffles (Tuber melanosporum), also known as Prigord ...
Breaking Biology News(10 mins):Brother of Hibiscus is found alive and well on Maui 2NXT-ID's Next Generation Biometric Smart Wallet Featured on NewsWatch Consumer Show on the History Channel and FYI Network Today, July 31st 2NXT-ID's Next Generation Biometric Smart Wallet Featured on NewsWatch Consumer Show on the History Channel and FYI Network Today, July 31st 3How black truffles deal with the jumpers in their genome 2
... synthetic life forms are at risk of being unduly ... are brought into the 21st century, an expert from The ... ANU College of Law takes a broad look at the ... biological inventions in his new book and the prognosis ...
... N.C. A small group of patients with a ... with an injectable microfoam experienced no neurological, visual or ... to preliminary results from a phase II trial. The ... D.C., at the annual scientific meeting of the Society ...
... CITY Two major eye diseases and leading causes of ... even prevented by drugs that activate a protein found ... Utah School of Medicine and several other institutions have ... diseases was prevented and even reversed when the protein, ...
Cached Biology News:Biotechnology needs 21st century patent system: Expert 2Improved foam for varicose veins found to be safe in preliminary results from phase II trial 2Blood vessel protein reverses macular degeneration, diabetic retinopathy in mice 2Blood vessel protein reverses macular degeneration, diabetic retinopathy in mice 3
Hepatocyte Differentiation Environment...
Mouse monoclonal [M2II-12] to MRP2 ( Abpromise for all tested applications). entrezGeneID: 1244 SwissProtID: Q92887...
...
Coating : Poly-D-Lysine ,Surface : ECM/attachment factors ,Surface area : 9.6 cm2 ,Dim nominal : 35 mm x 10 mm ,Vol working : 2.5-3.0 ml ...
Biology Products: